Don't miss out on Stem Cell & Regenerative Medicine Taiwan 2020

150+
High Profile Attendees
30 +
Industry Experts & Speakers
20+
Hours of Networking
10+
Case Studies

The Concept

Globally, the global regenerative medicine market  is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. The most significant number of marketed cell therapy products is used for the treatment of notably non-healing wounds/skin (46%) and muscular-skeletal injuries (35%). This trend will change as more and stem cell therapy products for cancer and heart disease complete their clinical trials and are approved for market release.

Adult stem cell leads the market due to low contamination during sub-culture and expansion, relatively small labor production and compatibility with the human body. Just the Induced pluripotent stem cells (IPSc’s) are expected to report revenue of over USD 4.5 billion by 2020, on account of the similar nature of its origin. With the continued growth of medical tourism hubs like India, Singapore, and Thailand, Asia is expected to maintain its place as the epicenter of stem cell research and therapy.

The Taiwan government aims to transform Taiwan into a regenerative medicine hub in Asia and to establish a robust regulatory and R& D environment for such procedures. According to reports, six-cell therapies recently approved by the government to treat medical issues, including cancer, degenerative joint disease, and skin wounds, are expected to be available at permitted medical centers.

Some of the significant challenges faced by Taiwan regenerative medicine companies are the higher cost of R&D for the development of RM products, clinical trial approvals, and other regulatory hindrances.

There are about 20 companies in Taiwan that are various stages of clinical development working on different areas of ATMP’s such as autologous DC’s, ADSCs, SMSC’s, DPC, DF, NK, allogenic DF, SMSC, ADSC, BMSCs CAR-T, Neo-T, and auto-activated T cell therapies. These companies are working on various cancers, osteoarthritis, stroke, kidney diseases, and so on.

Conference Agenda

Stem Cell & Regenerative Medicine Asia aims to be the platform for various stakeholders to converge and discuss challenges, prospects, and opportunities to advance regenerative medicine in Taiwan & Asia.

Registration



2 - Day Pass

 Solution Providers,Business Development, Marketing Profiles

2 - Day Pass

International Biopharma, International Academics, Technical Profiles

2 - Day Pass 

Taiwanese Biopharma/Academics (Partially subsidized by sponsors)

Expires on 30 APR 2020 

lIMITED super


SGD 3860

Approx. USD 2795

SGD 1925

Approx. USD 1395

SGD 960

Approx. USD 695

EXPIREs ON 26 June 2020

LIMITED SPECIAL

SGD 4135

Approx. USD 2995 

SGD 2205

Approx. USD 1595

SGD 1235

Approx. USD 895

EXPIREs ON 31 JUL 2020

EARLY BIRD


SGD 4410

Approx. USD 3195

SGD 2480

Approx. USD 1795

SGD 1790

Approx. USD 1295


sTANDARD RATE

SGD 4685

Approx. USD 3395

SGD 2755

Approx. USD 1995

SGD 2205

Approx. USD 1595

2020 Speakers

View All Speakers

Become A Sponsor

Venue & Accommodation

Novotel
Accommodation Booking Form

Conference Venue:
Grand Victoria Hotel,
Near 168, Jingye 4th Rd, Zhongshan District, Taipei City, Taiwan 104

For more information on venue and accommodation, kindly contact:
Sim Si Hui
Operations Executive
T: +65 3109 0224
E: sihui.sim@imapac.com

Don't miss out on Stem Cell & Regenerative Medicine Taiwan 2020

Speaking Opportunities

Aloysius Chong
Conference Producer

Registration & Media

Roohi Taragi
Senior Marketing Manager

Sponsorship Opportunities

Charmaine Poh
Business Development Manager - Sponsorship Sales
en_USEnglish
zh_CN简体中文 ja日本語 ko_KR한국어 zh_TW繁體中文 en_USEnglish
Open chat
Come chat with us!
Hello! How can I help you?
Powered by

Kindly fill the form below to receive your copy of the Program via email.
Thank you for you interest and cooperation.

Products of Interest*
Blood & Plasma ProductsAntibody TherapeuticsCell TherapyGene TherapyProtein TherapeuticsViral VaccinesImmunotherapeuticsOther BiologicsNon-biologicsMedical DeviceNone of the above

Subscribe to our mailing list

Kindly fill the form below to receive your copy of the Sponsorship Prospectus via email.
Thank you for your interest and cooperation!

Products of Interest*
Blood & Plasma ProductsAntibody TherapeuticsCell TherapyGene TherapyProtein TherapeuticsViral VaccinesImmunotherapeuticsOther BiologicsNon-biologicsMedical DeviceNone of the above

Subscribe to our mailing list

Loading...

Kindly fill the form below to receive your copy of the Program via email.
Thank you for you interest and cooperation.

Products of Interest*
Blood & Plasma ProductsAntibody TherapeuticsCell TherapyGene TherapyProtein TherapeuticsViral VaccinesImmunotherapeuticsOther BiologicsNon-biologicsMedical DeviceNone of the above

Subscribe to our mailing list

Kindly fill the form below to receive your copy of the Sponsorship Prospectus via email.
Thank you for your interest and cooperation!

Products of Interest*
Blood & Plasma ProductsAntibody TherapeuticsCell TherapyGene TherapyProtein TherapeuticsViral VaccinesImmunotherapeuticsOther BiologicsNon-biologicsMedical DeviceNone of the above

Subscribe to our mailing list

Kindly fill the form below to receive your copy of the Program via email.
Thank you for you interest and cooperation.

Products of Interest*
Blood & Plasma ProductsAntibody TherapeuticsCell TherapyGene TherapyProtein TherapeuticsViral VaccinesImmunotherapeuticsOther BiologicsNon-biologicsMedical DeviceNone of the above

Subscribe to our mailing list

Kindly fill the form below to receive your copy of the Sponsorship Prospectus via email.
Thank you for your interest and cooperation!

Products of Interest*
Blood & Plasma ProductsAntibody TherapeuticsCell TherapyGene TherapyProtein TherapeuticsViral VaccinesImmunotherapeuticsOther BiologicsNon-biologicsMedical DeviceNone of the above

Subscribe to our mailing list